Pliant Therapeutics (PLRX)

• Market cap: $70.6M
• 1 day: 0.88%
• 5 days: -1.72%
• 1 month: -0.87%
• 3 months: -12.98%
• 6 months: -8.06%
• Year to date: -8.8%
• 1 year: -16.18%
• 5 years: -96.36%
• 10 years: -94.65%
• Sector: Healthcare
• Industry: Biotechnology

About: Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novel integrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform.

Employees: 49